Advertisement
Screener

MEDICINOVA, INC. (MNOV) Stock-Based Compensation

2.8 / 5 stars · 68/120 Roast Me

MEDICINOVA, INC. Stock-Based Compensation

MEDICINOVA, INC. (MNOV) reported Stock-Based Compensation of $584.53 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.

Financial Statements › Cash Flow › Operating Activities

us-gaap:ShareBasedCompensation · last filed 2026-08-13

  • MEDICINOVA, INC. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $176.77K, a 13.73% decline year-over-year.
  • MEDICINOVA, INC. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $407.76K, a 42.60% increase year-over-year.
  • MEDICINOVA, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $180.56K, a 31.60% decline year-over-year.
  • MEDICINOVA, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $157.69K, a 68.77% decline year-over-year.
  • MEDICINOVA, INC. share-based payment arrangement, noncash expense for fiscal 2025 was $829.10K, a 30.43% decline from fiscal 2024.
  • MEDICINOVA, INC. share-based payment arrangement, noncash expense for fiscal 2024 was $1.19M, a 67.68% increase from fiscal 2023.
  • MEDICINOVA, INC. share-based payment arrangement, noncash expense for fiscal 2023 was $710.71K, a 10.61% increase from fiscal 2022.
  • MEDICINOVA, INC. share-based payment arrangement, noncash expense for fiscal 2022 was $642.52K, a 62.59% decline from fiscal 2021.
Period endShare-based Payment Arrangement, Noncash Expense 3 monthShare-based Payment Arrangement, Noncash Expense 3 month as first filedShare-based Payment Arrangement, Noncash Expense 6 monthShare-based Payment Arrangement, Noncash Expense 9 monthShare-based Payment Arrangement, Noncash Expense 12 monthShare-based Payment Arrangement, Noncash Expense 129 monthShare-based Payment Arrangement, Noncash Expense 132 monthShare-based Payment Arrangement, Noncash Expense 135 monthShare-based Payment Arrangement, Noncash Expense 138 monthShare-based Payment Arrangement, Noncash Expense 141 monthShare-based Payment Arrangement, Noncash Expense 144 monthShare-based Payment Arrangement, Noncash Expense 147 monthShare-based Payment Arrangement, Noncash Expense 150 monthShare-based Payment Arrangement, Noncash Expense 153 monthShare-based Payment Arrangement, Noncash Expense 156 month
2026-06-30$176.77K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13
$584.53K
10-Q · filed 2026-08-13
$765.09K
derived: sum of 3 quarters · filed 2026-08-13
$922.78K
derived: sum of 4 quarters · filed 2026-08-13
2026-03-31$407.76K
10-Q · filed 2026-05-14
$588.32K
derived: sum of 2 quarters · filed 2026-05-14
$746.02K
derived: sum of 3 quarters · filed 2026-05-14
$950.91K
derived: sum of 4 quarters · filed 2026-08-13
2025-12-31$180.56K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10
$338.25K
derived: sum of 2 quarters · filed 2026-03-10
$543.15K
derived: sum of 3 quarters · filed 2026-08-13
$829.10K
10-K · filed 2026-03-10
2025-09-30$157.69K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12
$362.59K
derived: sum of 2 quarters · filed 2026-08-13
$648.53K
10-Q · filed 2025-11-12
$912.52K
derived: sum of 4 quarters · filed 2026-08-13
2025-06-30$204.90K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13
$490.84K
10-Q · filed 2026-08-13
$754.83K
derived: sum of 3 quarters · filed 2026-08-13
$1.26M
derived: sum of 4 quarters · filed 2026-08-13
2025-03-31$285.94K
10-Q · filed 2026-05-14
$549.94K
derived: sum of 2 quarters · filed 2026-05-14
$1.05M
derived: sum of 3 quarters · filed 2026-05-14
$1.26M
derived: sum of 4 quarters · filed 2026-05-14
2024-12-31$263.99K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10
$768.86K
derived: sum of 2 quarters · filed 2026-03-10
$976.31K
derived: sum of 3 quarters · filed 2026-03-10
$1.19M
10-K · filed 2026-03-10
2024-09-30$504.86K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12
$712.32K
derived: sum of 2 quarters · filed 2025-11-12
$927.75K
10-Q · filed 2025-11-12
$690.34K
derived: sum of 4 quarters · filed 2025-11-12
2024-06-30$207.46K
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14
$422.88K
10-Q · filed 2025-08-14
$185.48K
derived: sum of 3 quarters · filed 2025-08-14
$404.62K
derived: sum of 4 quarters · filed 2025-08-14
2024-03-31$215.43K
10-Q · filed 2025-05-13
-$21.98K
derived: sum of 2 quarters · filed 2025-05-13
$197.17K
derived: sum of 3 quarters · filed 2025-05-13
$522.88K
derived: sum of 4 quarters · filed 2025-05-13
2023-12-31-$237.41K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-19
-$18.26K
derived: sum of 2 quarters · filed 2025-02-19
$307.45K
derived: sum of 3 quarters · filed 2025-02-19
$710.71K
10-K · filed 2025-02-19
2023-09-30$219.14K
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13
$544.85K
derived: sum of 2 quarters · filed 2024-11-13
$948.12K
10-Q · filed 2024-11-13
$1.08M
derived: sum of 4 quarters · filed 2024-11-13
2023-06-30$325.71K
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08
$728.97K
10-Q · filed 2024-08-08
$857.64K
derived: sum of 3 quarters · filed 2024-08-08
$1.02M
derived: sum of 4 quarters · filed 2024-08-08
2023-03-31$403.26K
10-Q · filed 2024-05-09
$531.93K
derived: sum of 2 quarters · filed 2024-05-09
$690.23K
derived: sum of 3 quarters · filed 2024-05-09
$964.73K
derived: sum of 4 quarters · filed 2024-05-09
2022-12-31$128.67K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-15
$286.97K
derived: sum of 2 quarters · filed 2024-02-15
$561.47K
derived: sum of 3 quarters · filed 2024-02-15
$642.52K
10-K · filed 2024-02-15
2022-09-30$158.30K
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09
$432.80K
derived: sum of 2 quarters · filed 2023-11-09
$513.85K
10-Q · filed 2023-11-09
-$243.12K
derived: sum of 4 quarters · filed 2023-11-09
2022-06-30$274.50K
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09
$355.56K
10-Q · filed 2023-08-09
-$401.42K
derived: sum of 3 quarters · filed 2023-08-09
$177.53K
derived: sum of 4 quarters · filed 2023-08-09
2022-03-31$81.05K
10-Q · filed 2023-05-11
-$675.92K
derived: sum of 2 quarters · filed 2023-05-11
-$96.97K
derived: sum of 3 quarters · filed 2023-05-11
$658.93K
derived: sum of 4 quarters · filed 2023-05-11
2021-12-31-$756.97K
derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-03-28
-$178.03K
derived: sum of 2 quarters · filed 2023-03-28
$577.88K
derived: sum of 3 quarters · filed 2023-03-28
$1.72M
10-K/A · filed 2023-03-28
2021-09-30$578.94K
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10
$1.33M
derived: sum of 2 quarters · filed 2022-11-10
$2.47M
10-Q · filed 2022-11-10
$2.87M
derived: sum of 4 quarters · filed 2022-11-10
2021-06-30$755.90K
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11
$1.90M
10-Q · filed 2022-08-11
$2.29M
derived: sum of 3 quarters · filed 2022-08-11
$3.33M
derived: sum of 4 quarters · filed 2022-08-11
2021-03-31$1.14M
10-Q · filed 2022-05-12
$1.54M
derived: sum of 2 quarters · filed 2022-05-12
$2.57M
derived: sum of 3 quarters · filed 2022-05-12
$3.72M
derived: sum of 4 quarters · filed 2022-05-12
2020-12-31$398.05K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16
$1.43M
derived: sum of 2 quarters · filed 2022-02-16
$2.58M
derived: sum of 3 quarters · filed 2022-02-16
$3.18M
10-K · filed 2022-02-16
2020-09-30$1.03M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12
$2.18M
derived: sum of 2 quarters · filed 2021-11-12
$2.78M
10-Q · filed 2021-11-12
$1.97M
derived: sum of 4 quarters · filed 2021-11-12
2020-06-30$1.15M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12
$1.74M
10-Q · filed 2021-08-12
$940.32K
derived: sum of 3 quarters · filed 2021-08-12
$1.31M
derived: sum of 4 quarters · filed 2021-08-12
2020-03-31$596.38K
10-Q · filed 2021-05-13
-$206.83K
derived: sum of 2 quarters · filed 2021-05-13
$167.01K
derived: sum of 3 quarters · filed 2021-05-13
$2.01M
derived: sum of 4 quarters · filed 2021-05-13
2019-12-31-$803.21K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-19
-$429.37K
derived: sum of 2 quarters · filed 2021-02-19
$1.41M
derived: sum of 3 quarters · filed 2021-02-19
$4.11M
10-K · filed 2021-02-19
2019-09-30$373.84K
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-26
$2.22M
derived: sum of 2 quarters · filed 2020-10-26
$4.92M
10-Q · filed 2020-10-26
$3.16M
derived: sum of 4 quarters · filed 2020-10-26
2019-06-30$1.84M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-28
$4.54M
10-Q · filed 2020-07-28
$2.79M
derived: sum of 3 quarters · filed 2020-07-28
$7.49M
derived: sum of 4 quarters · filed 2020-07-28
2019-03-31$2.70M
10-Q · filed 2020-04-23
$947.91K
derived: sum of 2 quarters · filed 2020-04-23
$5.65M
derived: sum of 3 quarters · filed 2020-04-23
$6.45M
derived: sum of 4 quarters · filed 2020-04-23
2018-12-31-$1.75M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-13
$2.95M
derived: sum of 2 quarters · filed 2020-02-13
$3.75M
derived: sum of 3 quarters · filed 2020-02-13
$6.33M
10-K · filed 2020-02-13
2018-09-30$4.70M
10-Q · filed 2018-10-25
$5.50M
derived: sum of 2 quarters · filed 2018-10-25
$8.08M
10-Q · filed 2019-10-24
$9.05M
derived: sum of 4 quarters · filed 2019-04-25
2018-06-30$800.00K
10-Q · filed 2018-07-23
$3.35M
10-Q · filed 2019-07-25
$4.35M
derived: sum of 3 quarters · filed 2019-04-25
$5.85M
derived: sum of 4 quarters · filed 2019-04-25
2018-03-31$2.53M
10-Q · filed 2019-04-25
$3.55M
derived: sum of 2 quarters · filed 2019-04-25
$5.05M
derived: sum of 3 quarters · filed 2019-04-25
$5.75M
derived: sum of 4 quarters · filed 2019-04-25
2017-12-31$1.02M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-13
$2.52M
derived: sum of 2 quarters · filed 2019-02-13
$3.22M
derived: sum of 3 quarters · filed 2019-02-13
$4.47M
10-K · filed 2019-02-13
2017-09-30$1.50M
10-Q · filed 2018-10-25
$2.20M
derived: sum of 2 quarters · filed 2018-10-25
$3.45M
10-Q · filed 2018-10-25
$3.38M
derived: sum of 4 quarters · filed 2019-02-13
2017-06-30$700.00K
10-Q · filed 2018-07-23
$1.93M
10-Q · filed 2018-07-23
$1.88M
derived: sum of 3 quarters · filed 2019-02-13
$3.08M
derived: sum of 4 quarters · filed 2019-02-13
2017-03-31$1.17M
10-Q · filed 2018-04-25
$1.18M
derived: sum of 2 quarters · filed 2019-02-13
$2.38M
derived: sum of 3 quarters · filed 2019-02-13
$3.68M
derived: sum of 4 quarters · filed 2019-02-13
2016-12-31$11.19K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-13
$1.21M
derived: sum of 2 quarters · filed 2019-02-13
$2.51M
derived: sum of 3 quarters · filed 2019-02-13
$3.97M
10-K · filed 2019-02-13
2016-09-30$1.20M
10-Q · filed 2017-10-23
$2.50M
derived: sum of 2 quarters · filed 2017-10-23
$3.96M
10-Q · filed 2017-10-23
$4.82M
derived: sum of 4 quarters · filed 2018-02-13
2016-06-30$1.30M
10-Q · filed 2017-07-26
$2.77M
10-Q · filed 2017-07-26
$3.62M
derived: sum of 3 quarters · filed 2018-02-13
$3.72M
derived: sum of 4 quarters · filed 2018-02-13
2016-03-31$1.44M
10-Q · filed 2017-04-26
$2.32M
derived: sum of 2 quarters · filed 2018-02-13
$2.42M
derived: sum of 3 quarters · filed 2018-02-13
$2.92M
derived: sum of 4 quarters · filed 2018-02-13
2015-12-31$881.69K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-13
$981.69K
derived: sum of 2 quarters · filed 2018-02-13
$1.48M
derived: sum of 3 quarters · filed 2018-02-13
$2.03M
10-K · filed 2018-02-13
2015-09-30$100.00K
10-Q · filed 2016-10-25
$84.14K
10-Q · filed 2015-10-29
$600.00K
derived: sum of 2 quarters · filed 2016-10-25
$1.14M
10-Q · filed 2016-10-25
$1.77M
derived: sum of 4 quarters · filed 2017-02-14
2015-06-30$500.00K
10-Q · filed 2016-07-26
$546.37K
10-Q · filed 2015-07-30
$1.06M
10-Q · filed 2016-07-26
$1.67M
derived: sum of 3 quarters · filed 2017-02-14
$2.16M
derived: sum of 4 quarters · filed 2017-02-14
2015-03-31$513.30K
10-Q · filed 2016-04-27
$1.17M
derived: sum of 2 quarters · filed 2017-02-14
$1.66M
derived: sum of 3 quarters · filed 2017-02-14
$1.90M
derived: sum of 4 quarters · filed 2017-02-14
2014-12-31$653.94K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-14
$1.15M
derived: sum of 2 quarters · filed 2017-02-14
$1.38M
derived: sum of 3 quarters · filed 2017-02-14
$1.64M
10-K · filed 2017-02-14
2014-09-30$497.68K
10-Q · filed 2015-10-29
$729.00K
derived: sum of 2 quarters · filed 2015-10-29
$984.10K
10-Q · filed 2015-10-29
$1.48M
derived: sum of 4 quarters · filed 2015-10-29
2014-06-30$231.32K
10-Q · filed 2015-07-30
$486.42K
10-Q · filed 2015-07-30
$983.78K
derived: sum of 3 quarters · filed 2015-07-30
$1.18M
derived: sum of 4 quarters · filed 2015-07-30
2014-03-31$255.10K
10-Q · filed 2015-05-11
$752.46K
derived: sum of 2 quarters · filed 2015-05-11
$950.25K
derived: sum of 3 quarters · filed 2015-05-11
$1.31M
derived: sum of 4 quarters · filed 2015-05-11
2013-12-31$497.36K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12
$695.16K
derived: sum of 2 quarters · filed 2015-03-12
$1.06M
derived: sum of 3 quarters · filed 2015-03-12
$1.22M
10-K · filed 2015-03-12
2013-09-30$197.80K
10-Q · filed 2014-11-13
$561.38K
derived: sum of 2 quarters · filed 2014-11-13
$719.08K
10-Q · filed 2014-11-13
$888.35K
derived: sum of 4 quarters · filed 2014-11-13
$51.11M
10-Q · filed 2013-11-07
2013-06-30$363.59K
10-Q · filed 2014-08-13
$521.29K
10-Q · filed 2014-08-13
$690.55K
derived: sum of 3 quarters · filed 2014-08-13
$869.41K
derived: sum of 4 quarters · filed 2014-08-13
$50.91M
10-Q · filed 2013-08-08
2013-03-31$157.70K
10-Q · filed 2014-05-08
$326.96K
derived: sum of 2 quarters · filed 2014-05-08
$505.83K
derived: sum of 3 quarters · filed 2014-05-08
-$59.94K
derived: sum of 4 quarters · filed 2014-05-08
$50.55M
10-Q · filed 2013-05-08
2012-12-31$169.26K
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-27
$348.13K
derived: sum of 2 quarters · filed 2014-03-27
-$217.64K
derived: sum of 3 quarters · filed 2014-03-27
$709.65K
10-K · filed 2014-03-27
$50.39M
10-K · filed 2013-03-28
2012-09-30$178.86K
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07
-$386.91K
derived: sum of 2 quarters · filed 2013-11-07
$540.38K
10-Q · filed 2013-11-07
$981.88K
derived: sum of 4 quarters · filed 2013-11-07
$50.22M
10-Q · filed 2012-11-08
2012-06-30-$565.77K
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08
$361.52K
10-Q · filed 2013-08-08
$803.02K
derived: sum of 3 quarters · filed 2013-08-08
$1.40M
derived: sum of 4 quarters · filed 2013-08-08
$50.04M
10-Q · filed 2012-08-09
2012-03-31$927.29K
10-Q · filed 2013-05-08
$1.37M
derived: sum of 2 quarters · filed 2013-05-08
$1.97M
derived: sum of 3 quarters · filed 2013-05-08
$2.12M
derived: sum of 4 quarters · filed 2013-05-08
$50.61M
10-Q · filed 2012-05-10
2011-12-31$441.50K
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-28
$1.04M
derived: sum of 2 quarters · filed 2013-03-28
$1.20M
derived: sum of 3 quarters · filed 2013-03-28
$1.37M
10-K · filed 2013-03-28
$49.68M
10-K · filed 2012-03-29
2011-09-30$598.14K
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08
$755.57K
derived: sum of 2 quarters · filed 2012-11-08
$931.25K
10-Q · filed 2012-11-08
$1.33M
derived: sum of 4 quarters · filed 2012-11-08
$49.24M
10-Q · filed 2011-11-14
2011-06-30$157.43K
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09
$333.11K
10-Q · filed 2012-08-09
$733.09K
derived: sum of 3 quarters · filed 2012-08-09
$1.27M
derived: sum of 4 quarters · filed 2012-08-09
$48.64M
10-Q · filed 2011-08-15
2011-03-31$175.68K
10-Q · filed 2012-05-10
$575.66K
derived: sum of 2 quarters · filed 2012-05-10
$1.11M
derived: sum of 3 quarters · filed 2012-05-10
2010-12-31$399.98K
derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-29
$935.55K
derived: sum of 2 quarters · filed 2012-03-29
$2.00M
10-K · filed 2012-03-29
2010-09-30$535.57K
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14
$1.60M
10-Q · filed 2011-11-14
2010-06-30$1.07M
10-Q · filed 2011-08-15
2009-12-31$2.37M
10-K · filed 2012-03-29

Similar stocks

Stock NameCountryMarket CapPE Ratio
NRX Pharmaceuticals, Inc. (NRXP)United States$0.131B-6.31
IMMUNIC, INC. (IMUX)United States$0.127B-1.88
Unicycive Therapeutics, Inc. (UNCY)United States$0.134B-3.70
TuHURA Biosciences, Inc./NV (HURA)United States$0.134B-4.88
INOVIO PHARMACEUTICALS, INC. (INO)United States$0.125B-1.35
Curanex Pharmaceuticals Inc (CURX)United States$0.138B
Aardvark Therapeutics, Inc. (AARD)United States$0.121B-1.80
CUMBERLAND PHARMACEUTICALS INC (CPIX)United States$0.121B-8.95
Coya Therapeutics, Inc. (COYA)United States$0.121B-6.35
Atrium Therapeutics, Inc. (RNA)United States$0.140B